U.S. Markets closed

Gilead's Rohini Mehtani, Ph.D. Reflects on The Importance of ASH21

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Northampton, MA --News Direct-- Gilead Sciences

As ASH21 wraps up, Gilead’s Rohini Mehtani, Ph.D. reflects on the importance of the meeting, particularly for people living with higher-risk myelodysplastic syndrome.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/gileads-rohini-mehtani-ph-d-reflects-on-the-importance-of-ash21-194498607